Premenopause

"Premenopause" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.

Descriptor ID	D017697
MeSH Number(s)	G08.686.157.500.812 G08.686.841.249.500.812
Concept/Terms	Premenopause Premenopause Premenopausal Period Pre-Menopause Pre-menopausal Period Period, Pre-menopausal

Below are MeSH descriptors whose meaning is more general than "Premenopause".

Biological Sciences [G]
Reproductive and Urinary Physiological Phenomena [G08]
Reproductive Physiological Phenomena [G08.686]
Climacteric [G08.686.157]
Menopause [G08.686.157.500]
Premenopause [G08.686.157.500.812]
Sexual Development [G08.686.841]
Climacteric [G08.686.841.249]
Menopause [G08.686.841.249.500]
Premenopause [G08.686.841.249.500.812]

Below are MeSH descriptors whose meaning is related to "Premenopause".

Below are MeSH descriptors whose meaning is more specific than "Premenopause".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Premenopause" by people in this website by year, and whether "Premenopause" was a major or minor topic of these publications.

Bar chart showing 29 publications over 14 distinct years, with a maximum of 4 publications in 2005 and 2010 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2002	0	1	1
2004	1	2	3
2005	1	3	4
2009	0	1	1
2010	1	3	4
2011	0	1	1
2014	0	3	3
2016	0	2	2
2017	0	1	1
2018	0	1	1
2020	1	3	4
2023	0	1	1
2025	2	0	2

Below are the most recent publications written about "Premenopause" by people in Profiles.

Dillon GA, Harvey RE, Limberg JK, Nicholson WT, Joyner MJ, Baker SE, Miller VM, Ranadive SM. Acute exogenous oestradiol augments endothelial and smooth muscle vasodilatory responsiveness in premenopausal but not postmenopausal females. J Physiol. 2025 04; 603(8):2301-2311.

View in: PubMed
Shenouda N, Stock JM, Chouramanis NV, Lincoln ZR, Wenner MM, Chirinos JA, Edwards DG. Favorable alterations in ventricular-arterial interactions across the menstrual cycle in healthy premenopausal women. Am J Physiol Heart Circ Physiol. 2025 03 01; 328(3):H648-H657.

View in: PubMed
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial. J Clin Oncol. 2023 11 01; 41(31):4864-4871.

View in: PubMed
Kim HJ, Noh WC, Lee ES, Jung YS, Kim LS, Han W, Nam SJ, Gong G-, Kim HJ, Ahn SH. Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer. Breast Cancer Res. 2020 05 27; 22(1):54.

View in: PubMed
Harvey RE, Ranadive SM, Limberg JK, Baker SE, Nicholson WT, Curry TB, Barnes JN, Joyner MJ. Forearm vasodilatation to a ?2 -adrenergic receptor agonist in premenopausal and postmenopausal women. Exp Physiol. 2020 05; 105(5):886-892.

View in: PubMed
Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M. Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents. Oncologist. 2020 06; 25(6):e900-e908.

View in: PubMed
Kim M, Kim H, Ahn SH, Tabatabaie V, Choi SW, Sohn G, Lee SB, Ko BS, Chung IY, Kim J, Lee JW, Son BH, Kim HJ. Changes in bone mineral density during 5?years of adjuvant treatment in premenopausal breast cancer patients. Breast Cancer Res Treat. 2020 Apr; 180(3):657-663.

View in: PubMed
Bathala P, Fereshteh Z, Li K, Al-Dossary AA, Galileo DS, Martin-DeLeon PA. Oviductal extracellular vesicles (oviductosomes, OVS) are conserved in humans: murine OVS play a pivotal role in sperm capacitation and fertility. Mol Hum Reprod. 2018 03 01; 24(3):143-157.

View in: PubMed
Loibl S, Turner NC, Ro J, Cristofanilli M, Iwata H, Im SA, Masuda N, Loi S, Andr? F, Harbeck N, Verma S, Folkerd E, Puyana Theall K, Hoffman J, Zhang K, Bartlett CH, Dowsett M. Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results. Oncologist. 2017 09; 22(9):1028-1038.

View in: PubMed
Kim HA, Ahn SH, Nam SJ, Park S, Ro J, Im SA, Jung YS, Yoon JH, Hur MH, Choi YJ, Lee SJ, Jeong J, Cho SH, Kim SY, Lee MH, Kim LS, Moon BI, Kim TH, Park C, Kim SJ, Jung SH, Park H, Gwak GH, Kang SH, Kim JG, Kim J, Choi SY, Lim CW, Kim D, Yoo Y, Song YJ, Kang YJ, Jung SS, Shin HJ, Lee KJ, Han SH, Lee ES, Han W, Kim HJ, Noh WC. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress. BMC Cancer. 2016 05 19; 16:319.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement